Concepedia

Publication | Open Access

Tumour-infiltrating neutrophils counteract anti-VEGF therapy in metastatic colorectal cancer

86

Citations

25

References

2018

Year

Abstract

Our findings implicate CD177 as a biomarker for bevacizumab and suggest VEGF/Ang2 inhibition as a strategy to overcome neutrophil associated resistance to anti-angiogenic treatment.

References

YearCitations

Page 1